NASDAQ:HSCSW Heart Test Laboratories 7/22/2026 Earnings Report $0.08 +0.01 (+22.95%) As of 03:55 PM Eastern This is a fair market value price provided by Massive. Learn more. Profile Heart Test Laboratories EPS ResultsActual EPSN/AConsensus EPS -$0.73Beat/MissN/AOne Year Ago EPSN/AHeart Test Laboratories Revenue ResultsActual RevenueN/AExpected Revenue$0.05 millionBeat/MissN/AYoY Revenue GrowthN/AHeart Test Laboratories Announcement DetailsQuarterDate7/22/2026TimeN/AConference Call DateN/AConference Call TimeN/AConference Call ResourcesCompany Profile Heart Test Laboratories Earnings HeadlinesHeart Test Laboratories Amends 2023 Equity Incentive PlanNovember 28, 2025 | tipranks.comHeart Test Laboratories Raises $2.8 Million in OfferingJuly 21, 2025 | tipranks.comBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid. The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned.June 24 at 1:00 AM | Awesomely, LLC (Ad)Heart Test Laboratories Updates Bylaws to Align with Texas LawJuly 1, 2025 | tipranks.comHeart Test Laboratories Receives FDA Breakthrough DesignationJune 4, 2025 | tipranks.comHeart Test Laboratories Secures Foundational Patent for AI-ECGJune 3, 2025 | tipranks.comSee More Heart Test Laboratories Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Heart Test Laboratories? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Heart Test Laboratories and other key companies, straight to your email. Email Address About Heart Test LaboratoriesHeart Test Laboratories (NASDAQ:HSCSW), a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.View Heart Test Laboratories ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Why KB Home Could Reward Patient Investors LaterWhy nVent Could Be a Long-Term AI Infrastructure WinnerChevron’s Microsoft Deal Turns Natural Gas Into an AI TradeMicron’s Sudden Plunge May Be an AI Buying ChanceMarathon Petroleum Is Back, But Cycles Still MatterLiquid Gold: The AI Cooling Retrofit TradeCopa Holdings May Be the Airline Stock Built to Break Out Upcoming Earnings NIKE (6/30/2026)PepsiCo (7/9/2026)Delta Air Lines (7/9/2026)Fastenal (7/13/2026)Bank of America (7/14/2026)The Goldman Sachs Group (7/14/2026)JPMorgan Chase & Co. (7/14/2026)Wells Fargo & Company (7/14/2026)Citigroup (7/14/2026)ASML (7/15/2026) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
